Bio-Rad Laboratories Pioneer Antibody Discovery Platform

Wednesday, 16 November, 2022 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad Laboratories has launched its Pioneer Antibody Discovery Platform, an antibody discovery service specifically designed to develop best-in-class biologic candidates.

The platform features a state-of-the-art phage display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using the company’s SpyDisplay selection technology. The antibody library is optimised for candidates that are suitable for drug development.

Tailored to each client’s specific requirements, the platform uses TrailBlazer technology to provide prototypes of therapeutic antibodies in a multitude of formats for streamlined lead identification. Final IgG antibodies will be delivered functionally characterised with a complete data package and sequences. Users will have exclusivity and ownership of antibody sequences.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Antibodies Inc recombinant antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen immune checkpoint reagents for immuno-oncology research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd